DBD
Price
$63.84
Change
+$0.66 (+1.04%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
2.07B
34 days until earnings call
Intraday BUY SELL Signals
GDRX
Price
$3.28
Change
+$0.01 (+0.31%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.13B
39 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DBD vs GDRX

DBD vs GDRX Comparison Chart in %
View a ticker or compare two or three
VS
DBD vs. GDRX commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBD is a Buy and GDRX is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
GDRX: Fundamental Ratings
GDRX
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
26
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DBDGDRX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
83%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (DBD: $63.18 vs. GDRX: $3.27)
Brand notoriety: DBD and GDRX are both not notable
DBD represents the Packaged Software, while GDRX is part of the Services to the Health Industry industry
Current volume relative to the 65-day Moving Average: DBD: 118% vs. GDRX: 63%
Market capitalization -- DBD: $2.07B vs. GDRX: $1.13B
DBD [@Packaged Software] is valued at $2.07B. GDRX’s [@Services to the Health Industry] market capitalization is $1.13B. The market cap for tickers in the [@Packaged Software] industry ranges from $39 to $244.09B. The market cap for tickers in the [@Services to the Health Industry] industry ranges from $708 to $45.33B. The average market capitalization across the [@Packaged Software] industry is $9.9B. The average market capitalization across the [@Services to the Health Industry] industry is $2.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DBD’s FA Score shows that 0 FA rating(s) are green while GDRX’s FA Score has 1 green FA rating(s).

  • DBD’s FA Score: 0 green, 5 red.
  • GDRX’s FA Score: 1 green, 4 red.
According to our system of comparison, GDRX is a better buy in the long-term than DBD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DBD’s TA Score shows that 5 TA indicator(s) are bullish while GDRX’s TA Score has 3 bullish TA indicator(s).

  • DBD’s TA Score: 5 bullish, 3 bearish.
  • GDRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, DBD is a better buy in the short-term than GDRX.

Price Growth

DBD (@Packaged Software) experienced а +1.14% price change this week, while GDRX (@Services to the Health Industry) price change was -2.68% for the same time period.

The average weekly price growth across all stocks in the @Packaged Software industry was -0.91%. For the same industry, the average monthly price growth was -5.54%, and the average quarterly price growth was +5.46%.

The average weekly price growth across all stocks in the @Services to the Health Industry industry was +1.81%. For the same industry, the average monthly price growth was +0.88%, and the average quarterly price growth was +23.72%.

Reported Earning Dates

DBD is expected to report earnings on Nov 05, 2026.

GDRX is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Packaged Software (-0.91% weekly)

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

@Services to the Health Industry (+1.81% weekly)

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

View a ticker or compare two or three
DBD
Daily Signal:
Gain/Loss:
GDRX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OVBC44.290.10
+0.24%
Ohio Valley Banc Corp
ASTC7.43-0.08
-1.07%
Astrotech Corp
TAK17.86-0.33
-1.81%
Takeda Pharmaceutical Company Limited
MLTX11.47-0.23
-1.97%
MoonLake Immunotherapeutics
MANE117.22-4.01
-3.31%
Veradermics Inc

DBD and

Correlation & Price change

A.I.dvisor indicates that over the last year, DBD has been loosely correlated with GDRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DBD jumps, then GDRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBD
1D Price
Change %
DBD100%
+3.20%
GDRX - DBD
49%
Loosely correlated
-0.61%
RAMP - DBD
47%
Loosely correlated
+0.48%
BLZE - DBD
43%
Loosely correlated
+1.36%
EEFT - DBD
42%
Loosely correlated
+1.22%
PAYO - DBD
41%
Loosely correlated
N/A
More